Congressional Research Service Reports - 206 Matching Results

Search Results

U.S.-Mexican Security Cooperation: The Mérida Initiative and Beyond: This report begins with a brief discussion of security challenges in Mexico and Mexico's security strategy. It then provides information on congressional funding and oversight of the Mérida Initiative, with details about each of the program's four pillars. The report concludes by raising policy issues that Congress may wish to consider.
U.S.-Mexican Security Cooperation: The Mérida Initiative and Beyond: This report provides a framework for examining the current status and future prospects for U.S.- Mexican security cooperation. It begins with a brief discussion of the threat that drug trafficking and related crime and violence pose to both nations, followed by an analysis of the evolution of the Mérida Initiative. The report then provides an overview of the Peña Nieto government's security strategy and how it is affecting the Mérida Initiative. The report then examines key aspects of the current U.S.-Mexican security strategy and concludes by raising policy issues that may affect bilateral efforts.
U.S.-Mexican Security Cooperation: The Mérida Initiative and Beyond: Increasing violence perpetrated by drug trafficking organizations and other criminal groups is threatening citizen security and governance in Mexico. Escalating violence has increased U.S. concerns about stability in Mexico, a key political and economic ally, and about the possibility of violence spilling over into the United States. In recent years, U.S.-Mexican security cooperation has increased significantly, largely as a result of the development and implementation of the Mérida Initiative, a counterdrug and anticrime assistance package for Mexico and Central America that was first proposed in October 2007. This report looks at the funding and Congressional oversight for this Initiative.
U.S.-Mexican Security Cooperation: The Mérida Initiative and Beyond: This report provides a framework for examining the current status and future prospects for U.S.- Mexican security cooperation. It begins with a brief discussion of the threat that drug trafficking and related crime and violence pose to both nations, followed by an analysis of the evolution of the Mérida Initiative. The report then provides an overview of the Peña Nieto government's security strategy and how it is affecting the Mérida Initiative. The report then examines key aspects of the current U.S.-Mexican security strategy and concludes by raising policy issues that may affect bilateral efforts.
U.S.-Mexican Security Cooperation: the Mérida Initiative and Beyond: This report looks at the funding and Congressional oversight for the U.S.-Mexican governments joint effort to curb drug trafficking and violence via the Initiative.
U.S.-Mexican Security Cooperation: the Mérida Initiative and Beyond: This report looks at the funding and Congressional oversight for this the joint U.S.-Mexico effort to curb drug trafficking and violence via the Initiative.
U.S.-Mexican Security Cooperation: The Mérida Initiative and Beyond: This report begins with a brief discussion of security challenges in Mexico and Mexico's security strategy. It then provides updated information on congressional funding and oversight of the Mérida Initiative before delving into its four pillars. The report concludes by raising policy issues that Congress may wish to consider as it continues to fund and oversee the Mérida Initiative and broader U.S.-Mexican security cooperation.
U.S.-Mexican Security Cooperation: the Mérida Initiative and Beyond: This report looks at the funding and Congressional oversight for this the joint U.S.-Mexico effort to curb drug trafficking and violence via the Initiative.
U.S.-Mexican Security Cooperation: the Mérida Initiative and Beyond: This report provides a framework for examining the current status and future prospects for U.S.- Mexican security cooperation. It begins with a brief discussion of the threat that drug trafficking and related crime and violence pose to both nations, followed by an analysis of the evolution of the Mérida Initiative. The report then provides an overview of the Peña Nieto government's security strategy and how it is affecting the Mérida Initiative. The report then examines key aspects of the current U.S.-Mexican security strategy and concludes by raising policy issues that may affect bilateral efforts.
International Drug Control Policy: Background and U.S. Responses: The global illegal drug trade represents a multi-dimensional challenge that has implications for U.S. national interests as well as the international community. This report discusses U.S. international policy frameworks and approaches in response to the issue.
The World Drug Problem: UNGA Convenes for a Special Session: This report briefly discusses the United Nations General Assembly (UNGA), which has convened in New York for a special session on "The World Drug Problem." It is the third time the UNGA will convene such a session on global drug issues. Previous special sessions on drugs were held in 1990 and 1998.
The World Drug Problem: UNGA Convenes for a Special Session: This report briefly discusses the United Nations General Assembly's (UNGA) 2016 special session on "The World Drug Problem." It is the third time the UNGA will convene such a session on global drug issues.
The World Drug Problem: UNGA Convenes for a Special Session: This report discusses the U.N. special session on the problem of drug abuse in the world. The interests and outcomes of the U.S. and U.N are also discussed.
Drunk Driving: Should Each State Be Required to Enact a 0.08 Blood Alcohol Concentration (BAC) Law?: At the 0.08 BAC level of alcohol, braking, steering, lane changing, and judgment are degraded and the driving performance of virtually all drivers is substantially impaired. During the debate on reauthorization of the federal surface transportation programs, an amendment that would require each state either to enact a 0.08 BAC law or face the loss of a portion of its Federal Highway Trust Fund monies passed the Senate and will likely be considered in the House. This proposal raises questions about the effectiveness and impacts of a 0.08 BAC law, the rights of states versus the federal government, and alternative ways to encourage the states to adopt stronger impaired driving countermeasures.
Federal Support for Drug Courts: In Brief: This report explains the concept of a "drug court,", how the term and programs have expanded to include wider meanings and serve additional subgroups, how the federal government supports drug courts, and research on the impact of drug courts on offenders and court systems. In addition, it briefly discusses how drug courts might provide an avenue for addressing the opioid epidemic and other emerging drug issues that Congress may consider.
The Opioid Epidemic and Federal Efforts to Address It: Frequently Asked Questions: This report answers common questions that have arisen as drug overdose deaths in the United States continue to increase. It does not provide a comprehensive overview of opioid abuse as a public health or criminal justice issue. The report is divided into the following sections: Overview of Opioid Abuse; Overview of Opioid Supply; Select Federal Agencies and Programs that Address Opioid Abuse; Recent Legislation; and Opioid Abuse and State Policies.
Reauthorizing the Office of National Drug Control Policy: Issues for Consideration: Report discussing the National Drug Control Strategy, the National Drug Control Budget, and the Office of National Drug Control Policy's (ONDCP) evaluation of the National Drug Control Strategy implementation. It also provides an analysis of selected legislative and oversight issues that Congress may consider when debating the reauthorization of ONDCP.
The Marijuana Policy Gap and the Path Forward: This report describes the federal response to state actions to decriminalize or legalize marijuana. It includes general information about marajuana and trends among states, the federal response, a discussion of the implications of legalization, and selected issues.
Mérida Initiative for Mexico and Central America: Funding and Policy Issues: In October 2007, the United States and Mexico announced the Mérida Initiative, a three-year program of U.S. assistance to Mexico and Central America to combat drug trafficking, gangs, and organized crime. This report provides an overview and discussion of the funding provided for Mérida, and presents several issues that Congress may consider as it oversees implementation of the Initiative and shapes its future direction.
Mérida Initiative for Mexico and Central America: Funding and Policy Issues: In October 2007, the United States and Mexico announced the Mérida Initiative, a three-year proposal for $1.4 billion in U.S. assistance to Mexico and Central America aimed at combating drug trafficking, gangs, and organized crime. This report provides an overview and discussion of the funding provided for Mérida, and presents several issues that Congress may consider as it oversees implementation of the Initiative.
Drunk Driving and the National Driver Register: At the 0.08 BAC level of alcohol, braking, steering, lane changing, and judgment are degraded and the driving performance of virtually all drivers is substantially impaired. During the debate on reauthorization of the federal surface transportation programs, an amendment that would require each state either to enact a 0.08 BAC law or face the loss of a portion of its Federal Highway Trust Fund monies passed the Senate and will likely be considered in the House. This proposal raises questions about the effectiveness and impacts of a 0.08 BAC law, the rights of states versus the federal government, and alternative ways to encourage the states to adopt stronger impaired driving countermeasures.
Colombia: The Problem of Illegal Narcotics and U.S. - Colombian Relations: The United States has long been concerned with Colombia as a major producer and trafficker of the illegal narcotics entering this country: first marijuana, then cocaine, and now also heroin. Colombia's drug trafficking business has been dominated by two cartels during the two decades in which cocaine trafficking became a major activity: first the Medellin cartel, which dominated during the 1980s and then the Cali cartel, which dominated during the early 1990s. With the arrests of the major Cali cartel leaders in the mid-1990s, independent traffickers have filled the void.
Veterans and Smoking-Related Illnesses: Congress Enacts Limits to Compensation: With enactment of P.L. 105-178 (H.R. 2400), the Transportation Equity Act for the 21 Century (TEA-21), Congress limited authority of the Department of Veterans st Affairs (VA) to grant service-connected compensation to veterans who, after the enactment date, claim that their smoking-related illnesses are traceable to tobacco use that began during their military service. P.L. 105-178's prohibition on most smokingrelated VA claims is the resolution of an issue with potentially explosive federal costs. Subsequent technical amendments included in P.L. 105-205, the Internal Revenue Service reform legislation, removed the implication that smoking may have been misconduct, and made other minor clarifications.
The Opioid Epidemic and the Food and Drug Administration: Legal Authorities and Recent Agency Action: This report focuses on the U.S. Food and Drug Administration (FDA) as a key player in federal efforts to curb the opioid epidemic. It provides an overview of FDA's role in approving new prescription drugs, including challenges of approval and regulation of opioid products; addresses FDA's multifaceted approach in responding, including recent agency action; and concludes with a discussion of selected opioid-related legislation in the 115th Congress.
Drug Certification of Mexico in 1999: Arguments For and Against Congressional Resolutions of Disapproval: This report presents arguments for and against congressional resolutions to disapprove President Clinton’s February 26, 1999 certification of Mexico as a fully cooperative country in efforts to control illicit narcotics.1 These resolutions (H.J.Res. 35--Bachus, and H.J.Res. 43--Mica and Gilman) would disapprove the President’s certification, but would permit him to avoid withholding of assistance to Mexico if he determined that vital national interests required such assistance.
Drug Certification Requirements and Congressional Modifications in 2001: This report provides a brief summary of the existing drug certification requirements for drug producing and drug-transit countries, background on the experience, criticisms, and reform efforts under these provisions; a summary of early congressional options and proposals advanced in 2001, with possible advantages and disadvantages; a summary of later initiatives with legislative activity; and (5) a tracking of legislative action on the major initiatives.
Drug Certification Requirements and Congressional Modifications in 2001-2002: This report provides a brief summary of the existing drug certification requirements for drug producing and drug-transit countries, background on the experience, criticisms, and reform efforts under these provisions; a summary of early congressional options and proposals advanced in 2001, with possible advantages and disadvantages; a summary of later initiatives with legislative activity; and (5) a tracking of legislative action on the major initiatives.
Drug Certification Requirements and Congressional Modifications in 2001-2002: This report provides a brief summary of the existing drug certification requirements for drug producing and drug-transit countries, background on the experience, criticisms, and reform efforts under these provisions; a summary of early congressional options and proposals advanced in 2001, with possible advantages and disadvantages; a summary of later initiatives with legislative activity; and (5) a tracking of legislative action on the major initiatives.
Drug Certification Requirements and Proposed Congressional Modifications in 2001: This report provides a brief summary of the existing drug certification requirements for drug producing and drug-transit countries, background on the experience, criticisms, and reform efforts under these provisions; a summary of early congressional options and proposals advanced in 2001, with possible advantages and disadvantages; a summary of later initiatives with legislative activity; and (5) a tracking of legislative action on the major initiatives.
Mexican Drug Certification Issues: U.S. Congressional Action, 1986-1998: No Description Available.
Mexican Drug Certification Issues: U.S. Congressional Action, 1986-2001: No Description Available.
Mexican Drug Certification Issues: U.S. Congressional Action, 1986-2002: No Description Available.
Mexico's Counter-Narcotics Efforts under Fox, December 2000 to April 2002: No Description Available.
Mexico's Counter-Narcotics Efforts under Fox, December 2000 to October 2004: No Description Available.
Mexico's Counter-Narcotics Efforts under Zedillo and Fox, December 1994-March 2001: No Description Available.
Mexico's Counter-Narcotics Efforts Under Zedillo, December 1994 to March 1998: No Description Available.
Mexico-U.S. Relations: Issues for Congress: This report explores the relationship between the United States and Mexico in terms of trade, drug trafficking, and cooperative disease control and management. Specifically, the report discusses the Mérida Initiative, the trade dispute involving the implementation of NAFTA trucking provisions, Secretary of State Clinton's March 2009 visit to Mexico, and the April 2009 outbreak of the H1N1 "swine flu" virus.
Smokeless Tobacco: Snuff and Chewing Tobacco; Bibliography-in-Brief, 1983-1987: No Description Available.
Smokeless Tobacco: Snuff and Chewing Tobacco; Bibliography-in-Brief, 1983-1987: No Description Available.
Haiti: Efforts to Restore President Aristide, 1991-1994: This report tracks the efforts to restore to office President Aristide of Haiti between the years 1991-1994. During this period, the main U.S. foreign policy concern was the restoration of the democratic process to Haiti. Closely related to this was the issue of Haitians attempting to flee to the United States by boat. Congressional concerns focused on human rights, Haitian migration, socioeconomic conditions, and drug trafficking.
Andean Counterdrug Initiative (ACI) and Related Funding Programs: FY2005 Assistance: This report discusses the funds and material support the U.S. has contributed to help Colombia and the Andean region fight drug trafficking since the development of Plan Colombia in 1999.
Andean Counterdrug Initiative (ACI) and Related Funding Programs: FY2006 Assistance: This report discusses the funds and material support the U.S. has contributed to help Colombia and the Andean region fight drug trafficking since the development of Plan Colombia in 1999.
Andean Counterdrug Initiative (ACI) and Related Funding Programs: FY2007 Assistance: This report discusses the funds and material support the U.S. has contributed to help Colombia and the Andean region fight drug trafficking since the development of Plan Colombia in 1999.
Colombia: Issues for Congress: Recent debate on U.S. policy toward Colombia has taken place in a context of concern for the volume of drugs readily available in the United States and elsewhere in the world, and regional security issues. The United States has made a significant commitment of funds and material support to help Colombia and the Andean region fight drug trafficking since the development of Plan Colombia in 1999. Congress passed legislation providing $1.3 billion in assistance for FY2000 (P.L. 106-246) and has provided more than $4 billion for programs in Colombia from FY2000 through FY2005 in both State Department and Defense Department counternarcotics accounts.
Drug Crop Eradication and Alternative Development in the Andes: The United States has supported drug crop eradication and alternative development programs in the Andes for decades. Colombia, Bolivia, and Peru collectively produce nearly the entire global supply of cocaine. In addition, Colombia has become a producer of high quality heroin, most of it destined for the United States and Europe. The United States provides counternarcotics assistance through the Andean Counterdrug Initiative (ACI). The program supports a number of missions, including interdiction of drug trafficking, illicit crop eradication, alternative development, and rule of law and democracy promotion. From FY2000 through FY2005, the United States has provided a total of about $4.3 billion in ACI funds.
ATPA Renewal: Background and Issues: This report outlines the various aspects of the Andean Trade Preference Act (ATPA), including significant dates and modifications. The ATPA extends special duty treatment to certain U.S. imports from Bolivia, Colombia, Ecuador, and Peru that meet domestic content and other requirements. The purpose of ATPA is to promote economic growth in the Andean region and to encourage a shift away from dependence on illegal drugs by supporting legitimate economic activities.
ATPA Renewal: Background and Issues: The Andean Trade Preference Act (ATPA) extends special duty treatment to certain U.S. imports from Bolivia, Colombia, Ecuador, and Peru that meet domestic content and other requirements. The purpose of ATPA is to promote economic growth in the Andean region and to encourage a shift away from dependence on illegal drugs by supporting legitimate economic activities. This report outlines the various aspects of the ATPA, including significant dates and modifications.
ATPA Renewal: Background and Issues: This report outlines the various aspects of the Andean Trade Preference Act (ATPA), including significant dates and modifications. The ATPA extends special duty treatment to certain U.S. imports from Bolivia, Colombia, Ecuador, and Peru that meet domestic content and other requirements. The purpose of ATPA is to promote economic growth in the Andean region and to encourage a shift away from dependence on illegal drugs by supporting legitimate economic activities.
ATPA Renewal: Background and Issues: The Andean Trade Preference Act (ATPA) extends special duty treatment to certain U.S. imports from Bolivia, Colombia, Ecuador, and Peru that meet domestic content and other requirements. The purpose of ATPA is to promote economic growth in the Andean region and to encourage a shift away from dependence on illegal drugs by supporting legitimate economic activities. This report outlines the impact and policy implications of the ATPA.
ATPA Renewal: Background and Issues: The Andean Trade Preference Act (ATPA) extends special duty treatment to certain U.S. imports from Bolivia, Colombia, Ecuador, and Peru that meet domestic content and other requirements. The purpose of ATPA is to promote economic growth in the Andean region and to encourage a shift away from dependence on illegal drugs by supporting legitimate economic activities. This report outlines the various aspects of the ATPA, including significant dates and modifications.

Congressional Research Service Reports - 206 Matching Results

Search Results

Add Filters

Applied Filters